COPD is a major cause of chronic morbidity and mortality throughout the world and is currently the fourth leading cause of death worldwide, with expected increases in the prevalence and mortality over ...
The mucolytic* drug carbocisteine can help slow the worsening of symptoms in patients with chronic obstructive pulmonary disease (COPD), and should be recognised as a treatment for the condition.
Proceeds to advance AER-01 into the clinic for treatment of chronic obstructive pulmonary disease (COPD); unique targeted approach to treating patients affected by mucus plugs "Pipeline-in-a-Product" ...
SAN DIEGO, July 31, 2012 /PRNewswire/ -- OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) ...
SAN DIEGO, July 31, 2012 /PRNewswire/ -- OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback